ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
0,00%
Bitcoin
66.907,61
-0,26%
Brent Oil
83,76
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Trillium Therapeutics Inc (TRIL)

  7. Trillium Therapeutics Inc (TRIL) Notícias

TRIL

Trillium Therapeutics (TRIL)

Trillium Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRIL
DataHoraFonteTítuloCódigoCompanhia
22/11/202108:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:TRILTrillium Therapeutics Inc
19/11/202117:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TRILTrillium Therapeutics Inc
19/11/202108:44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TRILTrillium Therapeutics Inc
17/11/202118:02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TRILTrillium Therapeutics Inc
17/11/202118:02Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:TRILTrillium Therapeutics Inc
17/11/202118:01Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:TRILTrillium Therapeutics Inc
17/11/202111:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TRILTrillium Therapeutics Inc
17/11/202111:24Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:TRILTrillium Therapeutics Inc
15/11/202119:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TRILTrillium Therapeutics Inc
12/11/202109:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TRILTrillium Therapeutics Inc
28/10/202118:00GlobeNewswire Inc.Trillium Therapeutics Receives Final Court Order Approving ArrangementNASDAQ:TRILTrillium Therapeutics Inc
26/10/202118:15GlobeNewswire Inc.Trillium Securityholders Approve Acquisition by PfizerNASDAQ:TRILTrillium Therapeutics Inc
20/10/202107:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TRILTrillium Therapeutics Inc
27/09/202107:08Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:TRILTrillium Therapeutics Inc
13/09/202117:55Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:TRILTrillium Therapeutics Inc
24/08/202118:14TipRanksPfizer to Purchase Rest of Trillium; Analysts Have Their SayNASDAQ:TRILTrillium Therapeutics Inc
23/08/202107:45GlobeNewswire Inc.Pfizer to Acquire Trillium Therapeutics Inc.NASDAQ:TRILTrillium Therapeutics Inc
13/08/202108:00GlobeNewswire Inc.Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial ResultsNASDAQ:TRILTrillium Therapeutics Inc
09/08/202108:00GlobeNewswire Inc.Trillium Therapeutics Announces Dosing of First Patient in Phase 1b/2 Study of TTI-622 in Combination With Azacitidine in TP53-Mutated Acute Myeloid LeukemiaNASDAQ:TRILTrillium Therapeutics Inc
06/07/202108:00GlobeNewswire Inc.Trillium Therapeutics Announces Dosing of First Patient in Phase 1b/2 Study of TTI-622 in Combination With Azacitidine and Ve...NASDAQ:TRILTrillium Therapeutics Inc
02/07/202117:35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:TRILTrillium Therapeutics Inc
30/06/202108:00GlobeNewswire Inc.Trillium Therapeutics Appoints Catherine Mackey, Ph.D., to Its Board of DirectorsNASDAQ:TRILTrillium Therapeutics Inc
29/06/202108:00GlobeNewswire Inc.Trillium Therapeutics Announces Dosing of First Patient in Phase 1b/2 Study of TTI-621 in Combination With Doxorubicin in Lei...NASDAQ:TRILTrillium Therapeutics Inc
25/06/202119:28GlobeNewswire Inc.Trillium Therapeutics Joins Russell 2000® and 3000® IndicesNASDAQ:TRILTrillium Therapeutics Inc
09/06/202108:00GlobeNewswire Inc.Trillium Announces Voting Results From the Annual General and Special Meeting of ShareholdersNASDAQ:TRILTrillium Therapeutics Inc
07/05/202108:00GlobeNewswire Inc.Trillium Therapeutics Reports First Quarter 2021 Operating and Financial ResultsNASDAQ:TRILTrillium Therapeutics Inc
28/04/202108:01GlobeNewswire Inc.Trillium Therapeutics Announces Dosing of First Patient in Phase 1b Study of TTI-622 in Combination With Carfilzomib and Dex...NASDAQ:TRILTrillium Therapeutics Inc
28/04/202108:00GlobeNewswire Inc.Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid...NASDAQ:TRILTrillium Therapeutics Inc
22/04/202108:00GlobeNewswire Inc.Trillium Therapeutics to Host Virtual R&D Day for Investors on April 28, 2021NASDAQ:TRILTrillium Therapeutics Inc
18/03/202117:05GlobeNewswire Inc.Trillium Therapeutics Reports Annual Operating and Financial Results and Sets Date for R&D DayNASDAQ:TRILTrillium Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRIL

Seu Histórico Recente

COIN
SMPTUSD
Smart Pharma Token
USOTC
GCCO
Garden City (PK)
CSE
LP
Leopard Lake Gold
UNSW
SMOLETH
smol
LSE
EX23
Citi Fun 27
NASDAQ
RCPT
RECEPTOS, INC.
ASX
BSLKOD
BIT
UB7RVH
Unicredit Bank
NASDAQ
PCSA
Processa Pharmaceuticals
ASX
AXMRA
NASDAQ
AAZFYXX
Hsbc Usa Inc Issuer Call...
UPBT
TONKRW
Tokamak Network Token
BIT
WMTS24
Mit Sim
BIT
P1HXE0
BNP Paribas Issuance
COIN
CPTNUSD
Contents Protocol Token
NYSE
VR-B
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados